The expression of Toll-like receptors 2, 4 and 9 in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis

Clinical and Experimental Immunology

Volumn 177, Issue 3, 2014, Pages 603-610

  Wang, H ^a,b,c,d   Gou, S J ^a,e   Zhao, M H ^a   Chen, M ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c Ministry of China   (China)

^d Ministry of Education   (China)

^e SICHUAN UNIVERSITY   (China)

Author keywords

ANCA; Toll like receptor; Vasculitis

Indexed keywords

CREATININE; NEUTROPHIL CYTOPLASMIC ANTIBODY; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; GLOMERULUS; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; KIDNEY BIOPSY; KIDNEY INJURY; KIDNEY INTERSTITIUM; MALE; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANCA; TOLL-LIKE RECEPTOR; VASCULITIS;

AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; VASCULITIS;

EID: 84904759601     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12365     Document Type: Article

References (35)

1. Jennette JC, Falk RJ, Bacon PA etal. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65:1-11.
2. Segelmark M, Wieslander J. IgG subclasses of antineutrophil cytoplasm autoantibodies (ANCA). Nephrol Dial Transplant 1993; 8:696-702.
3. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87:4115-4119.
4. Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996; 335:16-20.
5. Stegeman CA, Tervaert JW, Kallenberg CG. Co-trimoxazole and Wegener's granulomatosis: more than a coincidence. Nephrol Dial Transplant 1997; 12:652-655.
6. Tidman M, Olander R, Svalander C, Danielsson D. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med 1998; 244:133-141.
7. Carruthers DM, Watts RA, Symmons DP, Scott DG. Wegener's granulomatosis - increased incidence or increased recognition. Br J Rheumatol 1996; 35:142-145.
8. Koldingsnes W, Nossent H. Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis Rheum 2000; 43:2481-2487.
9. Aries PM, Herlyn K, Reinhold-Keller E, Latza U. No seasonal variation in the onset of symptoms of 445 patients with Wegener's granulomatosis. Arthritis Rheum 2008; 59:904.
10. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801.
11. Shirali AC, Goldstein DR. Tracking the toll of kidney disease. J Am Soc Nephrol 2008; 19:1444-1450.
12. Li M, Zhou Y, Feng G, Su SB. The critical role of Toll-like receptor signaling pathways in the induction and progression of autoimmune diseases. Curr Mol Med 2009; 9:365-374.
13. Huugen D, Xiao H, van Esch A, Falk RJ, Peutz-Kootstra CJ. Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am J Pathol 2005; 167:47-58.
14. Summers SA, van der Veen BS, O'Sullivan KM etal. Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis. Kidney Int 2010; 78:1263-1274.
15. Summers SA, Steinmetz OM, Gan PY etal. Toll-like receptor 2 induces Th17 myeloperoxidase autoimmunity while Toll-like receptor 9 drives Th1 autoimmunity in murine vasculitis. Arthritis Rheum 2011; 63:1124-1135.
16. Hurtado PR, Jeffs L, Nitschke J etal. CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis. BMC Immunol 2008; 9:34.
17. Tadema H, Abdulahad WH, Lepse N, Stegeman CA, Kallenberg CG, Heeringa P. Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission. Rheumatology (Oxf) 2011; 50:689-696.
18. Tadema H, Abdulahad WH, Stegeman CA, Kallenberg CG, Heeringa P. Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis. PLOS ONE 2011; 6:e24315.
19. Goncalves GM, Castoldi A, Braga TT, Camara NO. New roles for innate immune response in acute and chronic kidney injuries. Scand J Immunol 2011; 73:428-435.
20. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1725.
21. Bajema IM, Hagen EC, Hermans J etal. Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 1999; 56:1751-1758.
22. Bajema IM, Hagen EC, Hansen BE etal. The renal histopathology in systemic vasculitis: an international survey study of inter- and intra-observer agreement. Nephrol Dial Transplant 1996; 11:1989-1995.
23. Hauer HA, Bajema IM, van Houwelingen HC etal. European Vasculitis Study Group (EUVAS). Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 2002; 61:80-89.
24. Luqmani RA, Bacon PA, Moots RJ etal. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994; 87:671-678.
25. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2:675-680.
26. Wagner H. Endogenous TLR ligands and autoimmunity. Adv Immunol 2006; 91:159-173.
27. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006; 6:823-835.
28. Anders HJ, Banas B, Schlondorff D. Signaling danger: Toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 2004; 15:854-867.
29. Holle JU, Windmöller M, Lange C, Gross WL, Herlyn K, Csernok E. Toll-like receptor TLR2 and TLR9 ligation triggers neutrophil activation in granulomatosis with polyangiitis. Rheumatology (Oxf) 2013; 52:1183-1189.
30. Chen M, Yu F, Zhang Y, Zou WZ, Zhao MH, Wang HY. Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. Kidney Int 2005; 68:2225-2229.
31. Chen M, Yu F, Wang SX etal. Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis. Nephrol Dial Transplant 2007; 22:139-145.
32. Yu L, Wang L, Chen S. Endogenous Toll-like receptor ligands and their biological significance. J Cell Mol Med 2010; 14:2592-2603.
33. Chen J, John R, Richardson JA etal. Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney Int 2011; 79:288-299.
34. Fournier B. The function of TLR2 during staphylococcal diseases. Front Cell Infect Microbiol 2012; 2:167.
35. Kaisho T. Pathogen sensors and chemokine receptors in dendritic cell subsets. Vaccine 2012; 30:7652-7657.